Hepatocellular carcinoma surveillance in Australia: time to improve the diagnosis of cirrhosis and use liver ultrasound
- 24 February 2020
- journal article
- editorial
- Published by Wiley in Medical Journal of Australia
- Vol. 212 (7) , 297-+
Abstract
Click on the article title to read more.Keywords
This publication has 18 references indexed in Scilit:
- Hepatocellular carcinoma surveillance with ultrasound—cost-effectiveness, high-risk populations, uptakeBritish Journal of Radiology, 2018
- Rate of Nonsurveillance and Advanced Hepatocellular Carcinoma at Diagnosis in Chronic Liver DiseaseJournal of Clinical Gastroenterology, 2018
- Nonalcoholic fatty liver disease‐related cirrhosis is commonly unrecognized and associated with hepatocellular carcinomaHepatology Communications, 2017
- Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United StatesHepatology, 2017
- An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosisHepatology, 2016
- Medical resource utilization and costs among Australian patients with genotype 1 chronic hepatitis C: results of a retrospective observational studyJournal of Medical Economics, 2016
- Novel population‐based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is neededHepatology, 2015
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysisPLOS Medicine, 2014
- Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis CHepatology International, 2009
- Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosisAlimentary Pharmacology & Therapeutics, 2009